Stay updated on PANGEA-IMBBP Clinical Trial

Sign up to get notified when there's something new on the PANGEA-IMBBP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PANGEA-IMBBP Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected; observed differences appear to be minor UI/layout adjustments that do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T02:34:30.000Z thumbnail image
  3. Check
    33 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-06T15:51:42.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T09:50:35.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, indicating a minor patch. The Back to Top element was removed; no substantive changes to core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-15T00:01:29.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T20:42:51.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new drug information for several monoclonal antibodies and proteins. Notably, bemarituzumab has been reintroduced, while several previous drug categories and terms have been removed.
    Difference
    3%
    Check dated 2025-08-31T12:51:41.000Z thumbnail image

Stay in the know with updates to PANGEA-IMBBP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PANGEA-IMBBP Clinical Trial page.